BNET Industries
Omnicare Inc. (OCR) is in the Retail Industry
- Revenue
- Dec 31 2007
- $6.2B
- Profit
- Dec 31 2007
- $114.0M
- Market Cap
- Sep 04 2008
- $3.6B
Latest News and Analysis
Omnicare, Inc. Q2 2008 Earnings Call Transcript
Omnicare, Inc. OCR Q2 FY08 Earnings Call
Omnicare, Inc. Q1 2008 Earnings Call Transcript
Omnicare, Inc. Q1 2008 Earnings Call Transcript
Omnicare, Inc. Q4 2007 Earnings Call Transcript
Omnicare, Inc. Q4 2007 Earnings Call Transcript
Omnicare, Inc. Q4 2007 Earnings Call Transcript
Omnicare, Inc. Q4 2007 Earnings Call Transcript
Omnicare, Inc. Q3 2007 Earnings Call Transcript
Omnicare, Inc. Q3 2007 Earnings Call Transcript
Additional Resources
Omnicare Reports Second Quarter Results
- Quarterly Revenues and Adjusted Diluted EPS Exceed Expectations - - Quarterly Operating Cash Flow Continues Strong - - Revised Earnings Guidance Reflects Favorable Performance - COVINGTON, Ky. -- Omnicare, Inc. (NYSE:OCR), one of the nation's leading providers of pharmaceutical care for the elderly,...
Research and Markets: The Institutional Pharmacy Market is Dominated by Omnicare and Pharmerica, Who Combine to Serve Approximately Half of the Market
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/08dd92/institutional_phar) has announced the addition of the "Institutional Pharmacies Market Overview 2007" report to their offering. Institutional pharmacy describes the range of services provided by pharmacists to residents of nursing homes, hospitals, or hospice environments. In their role as medication therapy experts,...
Private Hospitals & Clinics - Portfolio Analysis Available Now for your Specialised Research
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/d1b0ee/private_hospitals) has announced the addition of the "Private Hospitals & Clinics UK - Portfolio Analysis" report to their offering. The Plimsoll Portfolio Analysis - Private Hospitals & Clinics is a comprehensive evaluation of the UK market. The revised and...
Omnicare to Release Second-Quarter Earnings and Hold Conference Call on Thursday, July 31, 2008
COVINGTON, Ky. -- Omnicare, Inc. (NYSE:OCR) will release its financial results for the second quarter ended June 30, 2008, on Thursday, July 31, 2008, before the opening of trading on the New York Stock Exchange. Omnicare will hold its quarterly conference call to discuss second...
Omnicare to Present at the Jefferies 2nd Annual Healthcare Conference
COVINGTON, Ky. -- Omnicare, Inc. (NYSE:OCR), the nation's leading provider of pharmaceutical care for the elderly, announced today that it will participate in the Jefferies 2nd Annual Healthcare Conference on June 24 at 10:45 a.m. ET in New York, New York. Presenting for Omnicare will be Joel...
Mergent, Inc. Announces Quarterly Rebalancing of HealthShares™ Indexes
NEW YORK, June 17 /PRNewswire/ -- Mergent, Inc., administrator for the HealthSharesTM Indexes, a series of 20 underlying indexes for the HealthSharesTM Exchange Traded Funds, today announced the quarterly rebalancing of the Indexes. The following securities will be added and deleted in the Indexes effective before...
Omnicare to Present at the Goldman Sachs Global Healthcare Conference
COVINGTON, Ky. -- Omnicare, Inc. (NYSE:OCR), the nation's leading provider of pharmaceutical care for the elderly, announced today that it will participate in the Goldman Sachs Global Healthcare Conference on June 11 at 3:20 p.m. PT at the Ritz Carlton Laguna Niguel in Dana Point, California. Presenting...
Walgreen to pay $35 million in drug switching
Walgreen Co. has agreed to pay $35 million to settle claims that it improperly switched patients' prescription drugs to more expensive ones in order to increase its reimbursement from Medicaid, the U.S. Justice Department announced yesterday. New Jersey and Pennsylvania will receive part of the money from the case,...
Walgreens Pays $35 Million, Settles Pharmacist-Whistleblower Qui Tam Drug Switching Allegations
Third National Pharmacy Settles Drug Switching Allegations; $120 Million Total Recovered For Federal and State Taxpayers This complete Settlement News Release is available at http://www.PharmacyFraudSettlement.com CHICAGO, June 4 /PRNewswire/ -- Walgreens today became the third national pharmacy to settle drug switching allegations...
Counseling the Board of Directors of a Delaware Corporation in Distress
Directors of a Delaware corporation have a statutory duty to direct the management of the business and affairs of the corporation.2 That is a proactive mandate that contemplates full engagement by directors.3 In carrying out that duty, directors are generally protected by the business judgment rule if they are...
Omnicare Holds Annual Stockholders' Meeting
COVINGTON, Ky. -- Omnicare, Inc. (NYSE:OCR), a leading provider of pharmaceutical care for the elderly, today held its Annual Meeting of Stockholders. At the meeting, Omnicare stockholders elected the nine directors who stood for election to the Company's Board of Directors to serve until the 2009 Annual Meeting...
Omnicare Declares Quarterly Cash Dividend
COVINGTON, Ky. -- The Board of Directors of Omnicare, Inc. (NYSE:OCR), a leading provider of pharmaceutical care for the elderly, declared today a quarterly cash dividend of 2.25 cents per share on its common stock. The dividend is payable June 23, 2008 to stockholders of record on June 13, 2008....
Omnicare Appoints John T. Crotty as Non-Executive Chairman of the Board of Directors
COVINGTON, Ky. -- Omnicare, Inc. (NYSE:OCR), one of the nation's leading providers of pharmaceutical care for the elderly, today announced the appointment of John T. Crotty as the new non-executive Chairman of its Board of Directors. Joel F. Gemunder, Omnicare's president and chief executive officer, said, "John has...
Omnicare to Present at the Bank of America Healthcare Conference
COVINGTON, Ky. -- Omnicare, Inc. (NYSE:OCR), one of the nation's leading providers of pharmaceutical care for the elderly, announced today that it will participate in the Bank of America Healthcare Conference on May 13 at 4:40 p.m. PT at the Four Seasons Hotel in Las Vegas, Nevada. Presenting for Omnicare...
Omnicare Reports First Quarter Results
- Quarterly Revenues and Adjusted Diluted EPS Exceed Expectations - - Quarterly Operating Cash Flow Reaches $142 Million - COVINGTON, Ky. -- Omnicare, Inc. (NYSE:OCR), one of the nation's leading providers of pharmaceutical care for the elderly, today reported financial results for its first quarter ended...
- Next »
- page 1 of 1
- « Previous
Sort byClose
View Related Content by Tag Close
- Incorporated: 1981
- CEO: Mr. Joel F. Gemunder
Omnicare is a geriatric pharmaceutical services company that provides pharmaceuticals and related ancillary pharmacy services to long-term healthcare institutions. Co. also provides operational software and support systems to long-term care pharmacy providers across the U.S. In addition, Co. provides pharmaceutical distribution and product support services for specialty pharmaceuticals. Further, Co. provides product development and research services for the pharmaceutical, biotechnology, medical device and diagnostic industries in 30 countries worldwide. At Dec 31 2007, Co. operated in two business segments: Pharmacy Services and Contract Research Organization services.
Key Competitors
Omnicare Inc. Company Info
Board of Directors
Mr. Joel F. Gemunder
Mr. John T. Crotty
Ms. Sandra E. Laney
Dr. Andrea R. Lindell Ph.D., R
Mr. John H. Timoney
Ms. Amy Wallman
Mr. Jeffrey W. Ubben
Mr. Steven J. Heyer
Mr. James D. Shelton
Contact Information
1600 RiverCenter II
100 East RiverCenter Boulevard
Covington, KY
859 392-3300
